Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK7 | P50613 | 17/20 | 0.86 |
| ▸ | CCNH | P51946 | 17/20 | 0.86 |
| ▸ | CCNK | O75909 | 16/20 | 0.86 |
| ▸ | CDK9 | P50750 | 16/20 | 0.86 |
| ▸ | CDK2 | P24941 | 16/20 | 0.86 |
| ▸ | CDK12 | Q9NYV4 | 15/20 | 0.86 |
| ▸ | CCNT1 | O60563 | 15/20 | 0.86 |
| ▸ | CDK13 | Q14004 | 14/20 | 0.86 |
| ▸ | CCNA2 | P20248 | 14/20 | 0.86 |
| ▸ | MNAT1 | P51948 | 9/20 | 0.86 |
| ▸ | CDK3 | Q00526 | 1/20 | 0.86 |
| ▸ | JUN | P05412 | 2/20 | 0.66 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.66 |
| ▸ | MAPK9 | P45984 | 2/20 | 0.66 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16655250 | 0.92 | CDK7 (1.00) | CDK7CCNHCCNKCDK9CDK2 | |
| SCHEMBL29392974 | 0.92 | CDK7 (1.00) | CDK7CCNHCCNKCDK9CDK2 | |
| SCHEMBL29434977 | 0.92 | CDK7 (1.00) | CDK7CCNHCCNKCDK9CDK2 | |
| SCHEMBL16655252 | 0.92 | CDK7 (1.00) | CDK7CCNHCCNKCDK9CDK2 | |
| SCHEMBL16664894 | 0.92 | CDK7 (1.00) | CDK7CCNHCCNKCDK9CDK2 | |
| SCHEMBL16655251 | 0.92 | CDK7 (1.00) | CDK7CCNHCCNKCDK9CDK2 | |
| SCHEMBL16655248 | 0.92 | CDK7 (1.00) | CDK7CCNHCCNKCDK9CDK2 | |
| SCHEMBL21561657 | 0.92 | CCNK (0.83) | CDK7CCNHCCNKCDK9CDK2 | |
| SCHEMBL16655115 | 0.89 | CCNK (1.00) | CDK7CCNHCCNKCDK9CDK2 | |
| SCHEMBL16655118 | 0.89 | CCNK (1.00) | CDK7CCNHCCNKCDK9CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117279636-A | Methods and compounds for modulating myotonic muscular dystrophy type 1 | 设计治疗公司 | 2023-12-22 | — | — | CN | disclosed |
| EP-4259133-A1 | METHODS AND COMPOUNDS FOR MODULATING MYOTONIC DYSTROPHY 1 | Design Therapeutics, Inc. (US) | 2023-10-18 | — | — | EP | disclosed |
| WO-2022126000-A1 | METHODS AND COMPOUNDS FOR MODULATING MYOTONIC DYSTROPHY 1 | Design Therapeutics, Inc. (US) | 2022-06-16 | — | — | WO | disclosed |